Abstract
Health-Related Quality of Life in Patients with Metastatic Basal Cell Carcinoma Treated with Cemiplimab: Analysis of a Phase 2 Open-Label Clinical Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have